bioMerieux

A world leader in the field of in vitro diagnostics for more than 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2015, revenues reached €1.965 billion with 90% of sales outside of France. bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Type
Public
HQ
Marcy-l'Étoile, FR
Founded
1963
Employees
9,376 (est)
bioMerieux was founded in 1963 and is headquartered in Marcy-l'Étoile, FR

bioMerieux Locations

Marcy-l'Étoile, FR

bioMerieux Metrics

bioMerieux Summary

Market capitalization

€5.99 B

Closing share price

€152
bioMerieux's current market capitalization is €5.99 B.

bioMerieux Market Value History

bioMerieux Online Presence

bioMerieux Company Life